Jia Weiping

Jia is an academician of the Chinese Academy of Engineering, a professor, and an endocrinologist. She works in the Shanghai Sixth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine, as director of the Shanghai Diabetes Institute and of the Proactive Healthcare Institute, at Shanghai Jiao Tong University. She focuses on the prediction, prognosis, and care of diabetes and related metabolic disorders. She has revealed the prevalence of diabetes and its complications in China, identified diabetes-susceptible genes in Chinese, established reference values of CGM, discovered the associations of FGF21 with NAFLD in humans, innovated AI screening systems on diabetic retinopathy, and developed a diabetes integrated care model with digital medicine. She has published over 300 original articles in journals, including BMJ, Nat Med, Nat Metab, Cell Metab, Sci Transl Med, Lancet Diabetes Endocrinol, Diabetes Care and Diabetes. She has received the Xiaoren Pan Distinguished Research Award for Epidemiology of Diabetes in Asia, the Ho Leung Ho Lee Prize for Science and Technology, and the National Science and Technology Progress Award.